Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises중간엽줄기세포(MSC) 유래 엑소좀, 코로나19 감염 환자를 위한 무세포 치료제로 활용: 진정한 기회와 약속의 범위Review Published on 2021-01-012022-09-11 Journal: Chemistry and physics of lipids [Category] SARS, 임상, 치료제, [키워드] acute respiratory distress acute respiratory distress syndrome antiviral medication Antiviral medications ARDS carrier carriers cells clinical trial coronavirus disease COVID-19 death derivative drugs effective Exosome Exosome based therapy Exosomes include induce Inflammation Intercellular communication medical need mesenchymal stem cell Mesenchymal stem cells miRNA miRNAs MOST mRNA mRNAs MSC MSC exsosomes Novel coronavirus novel coronavirus disease Patient Potential potential therapy respiratory distress second Secretome shown stem cell suppress syndrome therapy transfer Treatment treatment of COVID-19 Vaccine virus [DOI] 10.1016/j.chemphyslip.2020.105009 PMC 바로가기 [Article Type] Review